New partnership with Nippon Shinyaku strengthens the path toward developing and commercializing a promising therapy for patients with rare inflammatory diseases
Lausanne, Switzerland, 4 August...
Successful inspection highlights the company's commitment to quality, compliance, and reliable analytical testing for pharmaceutical development
Research Triangle Park, North Carolina, 28 July 2026 –...
Scientists from three leading universities join forces to develop a new generation of medicines targeting the deadliest malaria parasite
Boca Raton, Florida, 21 July 2026...
New specialized division aims to improve the safe and timely delivery of medicines, medical devices, and advanced therapies worldwide
Memphis, Tennessee, 14 July 2026 –...
Rapid adoption of artificial intelligence is reshaping patient care, diagnostics, and hospital operations, with strong growth expected over the next decade
New York, United States,...
